We are right at the centre of the most cutting edge thinking and are committed to seeking out new advances in medical science that we can bring to our patients.
Every year, our consultants attend national and international conferences, carry out research and write papers on new methods for treating cancer.
We work in partnership with Sarah Cannon Research Institute (SCRI) UK , a state of the art drug development unit and industry leader in clinical trials.
SCRIUK is dedicated to advancing solutions for patient care through clinical research.
Being at the heart of new drug developments we can deliver what we believe to be the most effective treatments at the earliest opportunity. Sometimes a treatment has been internationally recognised as a step forward but is not yet registered in the UK. When this happens, we do all we can to get hold of the drug for our patients in line with protocols agreed by the clinical governance team.
We are committed to bringing the most innovative cancer treatment to our patients sooner. One way in which we can do this is by participating in clinical trials and studies. Cancer research clinical trials and studies are designed to diagnose, treat and prevent cancer and also to manage the symptoms of cancer or the side effects of its treatment.
Clinical trials are available for all stages of cancer, and not only for those with advanced disease. Many of our consultants are personally involved in these clinical trials and so can advise you on what is relevant to your condition. If your consultant believes that you are eligible for enrolment into a clinical trial, they will liaise directly with the SCRIUK team and will continue to be closely involved in your care.
All clinical trials at Sarah Cannon Research UK follow the strict rules set by the Department of Health and are approved by an Ethics Committee in the UK, to ensure that the highest standards of safety are maintained at all times.
If you would like to know more about clinical trials at SCRI UK please visit their website at sarahcannonresearch.co.uk/
For a list of clinical trials open to recruitment at SCRI UK please visit: sarahcannonresearch.co.uk/for-patients/open-clinical-trials/open-and-recruiting/
Dr Hendrik-Tobias Arkenau, Executive Medical Director, Sarah Cannon Research Institute UK, said:
“Above all else, we are committed to the improvement of patient outcomes and advancement of medical science through innovation and quality execution of clinical research”.